AthleticsMD Clinical DeskSchedule an evaluation

Daily digest

What's trending, October 6, 2026

In the news

Early-onset menopause linked to increased symptoms of anxiety and depression

Medical Xpress reports on an observational University of Oulu study of more than 2,600 women from the Northern Finland Birth Cohort 1966, all 46 years old. Those already in the menopausal transition reported clinically significant anxiety symptoms more often, approximately 23% versus 16%, and depressive symptoms, just over 30% versus just under 25%. The associations held after accounting for smoking, alcohol, body mass index and education.

Why it matters: Relevant to midlife women and to the gynecology, primary care and mental health clinicians who refer them, noting the study covered Finnish women aged 46.

medicalxpress.com · October 6, 2026

Our summary →
In the news

Switching from GLP-1 Injections to Wegovy Pill Shows Additional Weight Loss of 4.1%

Healthline reports on the OCTANE study, a retrospective real-world analysis presented at the 2026 EASD meeting and not yet peer reviewed. Among 194 adults with overweight or obesity who switched from injectable semaglutide or tirzepatide to oral semaglutide, average weight loss was 4.1% over 3 months. The observational design cannot show the switch caused the loss, and weights were self-reported.

Why it matters: Relevant to Maryland adults on injectable GLP-1 weight loss medication who are curious about pill options, and to clinicians managing medical weight loss.

healthline.com · October 6, 2026

Our summary →
In the news

A camera combined with AI could help further diagnosis of movement disorders in newborns

Medical Xpress, republishing The Conversation, describes a small study by the researchers themselves in which an ordinary camera filmed infants for 60 seconds and AI analysed their movements. Among 25 infants in pediatric intensive care, five with genetically confirmed spinal muscular atrophy and 20 with normal neurological results, the algorithm classified the groups with an accuracy of 97%. Movement depth was a key feature.

Why it matters: Relevant to Maryland pediatric and neurology clinicians who assess or refer infants with reduced muscle tone, and to parents following research on spinal muscular atrophy.

medicalxpress.com · October 6, 2026

Our summary →
In the news

AA: Pulmonary Aspiration, Regurgitation Under Anesthesia More Likely With GLP-1 RAs

MPR, carrying a HealthDay News report, describes a UK national prospective cohort study of 47,039 adults at 119 sites undergoing procedures under an anesthetist, published in Anesthesia. 2.9% reported taking GLP-1 RAs. Pulmonary aspiration and/or regurgitation occurred in 0.12 and 1.41% of non-users and users, respectively (odds ratio, 11.39), most often during emergence. The observational study's authors call for further prospective research.

Why it matters: Relevant to readers taking GLP-1 medicines who are planning surgery, and to referring clinicians and anesthesia teams who follow perioperative research from UK cohorts.

empr.com · October 6, 2026

Our summary →
In the news

Planned Parenthood launches menopause care services in Dayton, Cincinnati locations

Yahoo News reports that Planned Parenthood Southwest Ohio is adding menopause and perimenopause care at its Dayton and Cincinnati health centers. Its advocacy arm is promoting House Bill 767, a proposed Ohio bill that would require insurers to cover these treatments. The bill has been referred to committee but has not had a first reading. The story also cites a Menopause Society study describing gaps in family medicine residency training.

Why it matters: Relevant to women navigating perimenopause or menopause, and to the clinicians who treat them, especially those following debates over access to care and insurance coverage for hormone therapy.

yahoo.com · October 6, 2026

Our summary →
In the news

Novel peptide approach reduces chronic neuropathic pain in mice

News-Medical reports on Boston Children's Hospital research in mice, published in Cell Reports Medicine, finding that a short lipidated peptide disrupting the interaction between the NaV 1.8 sodium channel and the scaffolding protein ankyrin-G quieted hyperexcitable pain-sensing neurons and reduced pain-like behaviors in mouse models while sparing acute protective pain. The work is preclinical and has been licensed to Mimetic Medicines for investigational development.

Why it matters: Relevant to Maryland clinicians and rehabilitation readers following early preclinical research into non-opioid approaches to chronic neuropathic pain.

news-medical.net · October 6, 2026

Our summary →
In the news

GLP-1s and NAION: Do Patients Need a Warning?

Medscape Medical News reports on federal litigation alleging GLP-1 drugs are linked to NAION, a rare optic nerve condition. European regulators list it as a very rare potential effect of semaglutide; US labels do not. The NAION case group grew to 247 cases from 29 in January. Ophthalmology groups call research findings mixed, and drugmakers say causation has not been established.

Why it matters: Relevant to Maryland adults weighing semaglutide or tirzepatide for medical weight loss, and to the prescribers and ophthalmologists who discuss these drugs with them.

medscape.com · October 6, 2026

Our summary →
In the news

Your Patient Lost Weight on a GLP-1. Can You Trust the eGFR?

Medscape reports that two small, short randomized trial analyses found no muscle-driven inflation of eGFR with semaglutide. In the SMART analysis of 101 adults with CKD without type 2 diabetes, about 9 kg extra weight loss did not track with eGFR changes. A Danish post hoc analysis of 48 patients saw a small creatinine rise. Clinicians discuss when cystatin C testing may help.

Why it matters: Relevant to Maryland clinicians who monitor kidney function in patients taking GLP-1 drugs, and to adults with chronic kidney disease in medical weight-loss programs.

medscape.com · October 6, 2026

Our summary →
In the news

Planned Parenthood launches menopause care services in Dayton, Cincinnati locations

Yahoo News reports that Planned Parenthood Southwest Ohio is adding menopause and perimenopause care at its Dayton and Cincinnati health centers. Its advocacy arm is promoting proposed Ohio legislation, House Bill 767, requiring insurers to cover these treatments. The bill was referred to the Ohio House Insurance Committee but has not had a first reading. The story also cites reported gaps in family medicine training.

Why it matters: Relevant to readers and referring clinicians following menopause care access and insurance coverage debates, though the story concerns Ohio services and proposed Ohio legislation.

yahoo.com · October 6, 2026

Our summary →
In the news

Women entering menopause early report increased anxiety and depression

News-Medical reports on a University of Oulu observational study of more than 2,600 women, all 46 years old, from the Northern Finland Birth Cohort 1966. Those already in the menopausal transition reported clinically significant anxiety symptoms more often, approximately 23 per cent versus 16 per cent. Depressive symptoms were also more common, and the associations held after accounting for smoking, alcohol, body mass index and education.

Why it matters: Relevant to women in their mid-40s approaching menopause and to the clinicians who refer them for preventive or mental health care.

news-medical.net · October 6, 2026

Our summary →

AthleticsMD Clinical Desk

Today's front page

The newest articles and the day's news on GLP-1 & weight loss, Metabolic health, Hormones and more.

Go to the front page →

AthleticsMD

Schedule an evaluation

AthleticsMD in Columbia and Laurel/Fort Meade builds prehabilitation, rehabilitation and physician-guided weight-loss plans around your own history.

Schedule an evaluation →